Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Business Wire•05/08/2026•16:01 ET
0
Whiz Insights
Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
2026 net product sales guidance increased to $680 million to $700 million
Get started
Create a free account to read the full story.